Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Fish and Richardson
Queensland Health
Chinese Patent Office
Cerilliant
Accenture
Johnson and Johnson
Dow
Farmers Insurance

Generated: October 22, 2017

DrugPatentWatch Database Preview

ELLA Drug Profile

« Back to Dashboard

What is the patent landscape for Ella, and what generic Ella alternatives are available?

Ella is a drug marketed by Lab Hra Pharma and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has sixty-three patent family members in twenty-six countries.

The generic ingredient in ELLA is ulipristal acetate. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ulipristal acetate profile page.

Summary for Tradename: ELLA

US Patents:5
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list31
Clinical Trials: see list8
Patent Applications: see list41
Drug Prices:see details
DailyMed Link:ELLA at DailyMed

Pharmacology for Tradename: ELLA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for ELLA

Drugname Dosage Strength RLD Submissiondate
ulipristal acetateTablets30 mgElla8/13/2014

Non-Orange Book Patents for Tradename: ELLA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,616,073Method for on-demand contraception► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ELLA

Country Document Number Estimated Expiration
Canada2745084► Subscribe
Colombia6400186► Subscribe
Japan5951480► Subscribe
World Intellectual Property Organization (WIPO)2010119029► Subscribe
Mexico2011006106► Subscribe
Russian Federation2542779► Subscribe
Slovenia2365800► Subscribe
World Intellectual Property Organization (WIPO)2010066749► Subscribe
Russian Federation2011127989► Subscribe
Japan2016188232► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Dow
Covington
UBS
McKinsey
AstraZeneca
Chinese Patent Office
Fish and Richardson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot